Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5781)
  3. Review (421)
  4. Editorial (196)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13278)
  2. Center for Hematologic Malignancies (10612)
  3. GSK Faculty (4482)
  4. Adult Leukemia (3673)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2705)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (340)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (330)
  5. Haematologica (292)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1530)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Practice patterns in the diagnosis of follicular lymphoma (FL): Report from the National Lymphocare Study (NLCS)
    Meeting Abstract

    Matasar, M. J.; Saxena, R.; Wong, E. K.; Filippa, D. A.; Zelenetz, A. D.
    Blood (2007)

    Fulltext@MSK | Save
  • Pilot study of a Wilms tumor protein (WT1) heteroclitic peptide vaccine in patients with myeloid and thoracic neoplasms
    Meeting Abstract

    Maslak, P. G.; Krug, L.; Chanel, S.; Dao, T.; James, L.; Tyson, L.; Bekele, S.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • CEACAM-1 is involved in graft-versus-host-discase in murine allogeneic bone marrow transplantation models
    Meeting Abstract

    Lu, S. X.; Willis, L.; Smith, M.; Suh, D.; King, C.; Bautista, J.; Chow, M.; Cabrera-Perez, J.; Hubbard, V.; Rotolo, J.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Discovery and validation of STAT-3 and ERK1/2 phosphorylation as critical for the function of alloactivated T cells in acute graft-versus-host-disease via a novel technique for drug discovery
    Meeting Abstract

    Lu, S. X.; Alpdogan, O.; Campos, R.; Wang, X.; Gao, G. J.; Chow, M.; Lin, J.; Suh, D.; King, C.; Hubbard, V. M.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • The importance of the human beta-globin locus control region HS1 and HS4 elements for therapeutic beta-globin gene expression in beta-thalassemic mice
    Meeting Abstract

    Lisowski, L.; Sadelain, M.
    Blood (2007)

    Fulltext@MSK | Save
  • Regulation of hematopoietic stem cell quiescence - A novel role for p53
    Meeting Abstract

    Liu, Y.; Elf, S. E.; Miyata, Y.; Sashida, G.; Deblasio, A.; Koff, A.; Nimer, S. D.
    Blood (2007)

    Fulltext@MSK | Save
  • Optimization of globin lentiviral vector design for the treatment of beta-thalassemia
    Meeting Abstract

    Lisowski, L.; Rivella, S.; Zhu, P.; Sadelain, M.
    Blood Cells, Molecules, and Diseases (2007)

    Fulltext@MSK | Save
  • Predictors of distress in older patients with cancer
    Meeting Abstract

    Li, D.; Patil, S.; Nelson, C.; Lichtman, S.; Tew, W.; Hamlin, P.; Zuckerman, E.; Gardes, J.; Limaye, S.; Kelly, E.; more...
    Journal of the American Geriatrics Society (2007)

    Fulltext@MSK | Save
  • Efficacy and long term survival of genetically modified T cells targeting CD19 in a syngeneic immune competent transgenic murine tumor model is dependent on prior lymphodepleting chemotherapy
    Meeting Abstract

    Lee, J.; Nikhamin, Y.; Imperato, G.; Cohen, A.; Sadelain, M.; Brentjens, R.
    Blood (2007)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, rituximab, and mitoxantrone (PCRM): A new highly active regimen for patients with chronic lymphocytic leukemia (CLL) previously treated with PCR or FCR
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Brentjens, R. J.; Jurcic, J. G.; Weiss, M. A.
    Blood (2007)

    Fulltext@MSK | Save